Table 4. Effects of CdCl2(C14H21N3O2) complex on liver function parameter in AOM-induced colon cancer study.
| Group | Total protein (g/L) | Albumin (g/L) | AST (IU/L) | ALT (IU/L) | GGT (IU/L) |
|---|---|---|---|---|---|
| Vehicle control group | 66.32 ± 0.44 | 11.3 ± 0.89 | 206.2 ± 2.48 | 61 ± 2.33 | 5.4 ± 0.3 |
| Cancer control group | 69.5 ± 39 | 10.27 ± 0.54 | 210.0 ± 3.60 | 66.2 ± 1.5 | 3.7 ± 0.6 |
| Positive control group | 73.6 ± 2.1 | 11.3 ± 0.89 | 182.0 ± 4.5 | 51.0 ± 0.87 | 6.1 ± 0.48 |
| Low dosage of complex (25 mg/kg) | 68.5 ± 0.67 | 11.4 ± 0.3 | 230.5 ± 6.1 | 70.5 ± 0.63 | 3.0 ± 0.1 |
| High dosage of complex (50 mg/kg) | 70.9 ± 1.1 | 11.0 ± 0.52 | 221 ± 3.8 | 61.5 ± 1.8 | 3.0 ± 0.1 |
Values are expressed as the means ± SEM There are no significant differences between groups. Significance was set at P < 0.05 compared with cancer control group. TB: total bilirubin; ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: G-glutamyl transferase.